MediGear International Corporation is a certified startup from Tokyo Institute of Technology. With the concept of “Beyond the Pill”, we offer "drug-free tumor-targeted minimally invasive therapy" that improves the QOL of cancer patients who have no therapeutic options left, and homogenizes medical care regardless of the skill level of doctors.
It is a therapy that obtains an antitumor effect without a drug by blocking the supply of oxygen and nutrients to cancer cells by locally administering a uniquely developed nanodevice, which we develop, to the tumor and specifically surrounding the tumor as a barrier.

about nano-devices

This therapy is being developed in collaboration with our company and the Kondo Laboratory, School of Life Science and Technology, Tokyo Institute of Technology